End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,785 KRW | -0.26% | -0.66% | -7.91% |
2023 | Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023. | CI |
2023 | Hyundai Pharmaceutical Co., Ltd.(KOSE:A004310) dropped from S&P Global BMI Index | CI |
Sales 2012 | 102B 75.46M | Sales 2013 | 108B 79.8M | Capitalization | 42.44B 31.32M |
---|---|---|---|---|---|
Net income 2012 | -4.85B -3.58M | Net income 2013 | 1.42B 1.04M | EV / Sales 2012 | 0.48 x |
Net Debt 2012 | 12.68B 9.35M | Net Debt 2013 | 6.12B 4.52M | EV / Sales 2013 | 0.45 x |
P/E ratio 2012 |
-7.47
x | P/E ratio 2013 |
30
x | Employees | 393 |
Yield 2012 |
2.39% | Yield 2013 |
2.32% | Free-Float | 58.96% |
1 day | -0.26% | ||
1 week | -0.66% | ||
Current month | +0.13% | ||
1 month | -2.20% | ||
3 months | -1.82% | ||
6 months | -5.14% | ||
Current year | -7.91% |
Managers | Title | Age | Since |
---|---|---|---|
Sang-Joon Lee
CEO | Chief Executive Officer | 47 | 03-02-27 |
Seok-Bong Lee
DFI | Director of Finance/CFO | 67 | 89-05-07 |
Young-Hak Kim
BRD | Director/Board Member | 62 | 07-10-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Han-Gu Lee
CHM | Chairman | 76 | 74-08-08 |
Cheon-Soo Ham
BRD | Director/Board Member | 77 | 99-02-04 |
Sang-Joon Lee
CEO | Chief Executive Officer | 47 | 03-02-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 3,785 | -0.26% | 28,167 |
24-05-02 | 3,795 | +0.40% | 34,959 |
24-04-30 | 3,780 | -0.53% | 22,561 |
24-04-29 | 3,800 | 0.00% | 21,412 |
24-04-26 | 3,800 | -0.26% | 34,677 |
End-of-day quote Korea S.E., May 02, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-7.91% | 76.65M | |
+19.98% | 43.67B | |
+20.67% | 22.51B | |
+14.56% | 14.6B | |
+14.32% | 13.74B | |
+44.72% | 11.91B | |
-8.37% | 7.04B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.90% | 5.42B |
- Stock Market
- Equities
- A004310 Stock